-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NexGrY7DCNId9Z8dg2R4r8jjONaieYbA7CqF7TUeQivCehBiNS+XUdZiTWwLtfpq PF9o6ECFef9K0WdXgzGXDQ== 0001209191-05-017452.txt : 20050324 0001209191-05-017452.hdr.sgml : 20050324 20050324172958 ACCESSION NUMBER: 0001209191-05-017452 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050323 FILED AS OF DATE: 20050324 DATE AS OF CHANGE: 20050324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORE LABORATORIES N V CENTRAL INDEX KEY: 0001000229 STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1017 BZ AMSTERDAM STREET 2: HERENGRACHT 424 CITY: THE NETHERLANDS STATE: P7 BUSINESS PHONE: 3124203191 MAIL ADDRESS: STREET 1: 6316 WINDFERN CITY: HOUSTON STATE: TX ZIP: 77040 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DENSON JOHN D CENTRAL INDEX KEY: 0001282545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14273 FILM NUMBER: 05702920 MAIL ADDRESS: STREET 1: 6316 WINDFERN ROAD CITY: HOUSTON STATE: TX ZIP: 77040 4 1 h22994_10jdd.xml MAIN DOCUMENT DESCRIPTION X0202 4 2005-03-23 0001000229 CORE LABORATORIES N V CLB 0001282545 DENSON JOHN D 6316 WINDFERN HOUSTON TX 77040 0 1 0 0 VP, Gen.Counsel & Secretary Performance Shares 0 2005-03-23 4 A 0 10000 0 A 2007-12-31 2007-12-31 Common Shares 10000 10000 D Represent contingent rights to acquire common shares ("Performance Shares") that are subject to a performance goal that is based on a calculated return on equity versus a pre-determined target return on equity of 20%. The return on equity is calculated by dividing earnings before interest and income tax from continuing operations over the performance period by ending shareholders' equity over the performance period ("ROE"). Unless there is a change in control, none of these shares will be issued if the ROE for Core Laboratories N.V. ("Core") is less than 20% for the three-year performance period. If Core's ROE for the performance period equals 20%, then 50% of the shares will be issued, and if Core's ROE for the performance period equals or exceeds 24%, then 100% of the shares will be issued. If Core's ROE for the performance period is greater than 20% but less than 24%, then the number of shares to be issued would be interpolated based on the terms of the agreement. If a change in control of Core occurs prior to the last day of the performance period and while the executive officer is employed by Core, then all of the executive officer's Performance Shares will vest as of the date of the change in control. 1 for 1 /s/ John D. Denson 2005-03-24 -----END PRIVACY-ENHANCED MESSAGE-----